Development of a lesion identification scheme for Acne inversa

Development of a lesion identification scheme for Acne inversa - LISAI

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023511

Enrollment

Registered

2021-02-15

Start date

2021-09-23

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L73.2

Interventions

Group 1: The study aims at investigating whether patients are able to identify their lesions in accordance with physicians using a lesion identification scheme (LISAI). The concordance of the physicia

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 18 2. Hidradenitis suppurativa/Acne inversa of any severity (Hurley I-III). 3. Patient is treated with LAight and documented via the software 4. Smartphone or tablet with access to LISAI.

Exclusion criteria

Exclusion criteria: Insufficient knowledge of the German language

Design outcomes

Primary

Measure	Time frame
Cohen's kappa is used for interrater reliability between physicians/professionals and patients (agreement between 50 physician/professional ratings (rater 1) with 50 patient ratings (rater 2)).	—

Countries

Germany

Contacts

Public ContactMichael Schultheis

Universitätsmedizin der Johannes Gutenberg-Universität Mainz

Michael.Schultheis@unimedizin-mainz.de+49-6131-17-5732

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026